S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

KZR Kezar Life Sciences Inc

5.87

0.00 (0.00%)

Pre Market

Last Updated: 06:17:39

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Kezar Life Sciences Charts.

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Kezar Life Sciences Charts.

Kezar Life Sciences Inc News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 6 March 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025
Tuesday 18 February 2025 (4 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 5 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (4 months ago) • Edgar (US Regulatory)

More Kezar Life Sciences Inc News Articles

Halozyme Therapeutics

Hedera Hashgraph

Good Vibrations Shoes (PK)

TransCode Therapeutics

Cann American (CE)

CyberFuels (PK)

Fannie Mae (QB)

Impact Fusion (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Brookmount Explorations (PK)

Global Developments (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions